Fibrocell Science (FCSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,207 | -4,570 | -12,687 | -1,639 | -13,076 |
| Depreciation Amortization | 456 | 226 | 967 | 716 | 495 |
| Income taxes - deferred | N/A | N/A | -2,500 | -2,500 | -2,500 |
| Accounts receivable | -10 | 45 | -60 | -82 | -33 |
| Accounts payable and accrued liabilities | 221 | 324 | -966 | -186 | -1,214 |
| Other Working Capital | 645 | 459 | -1,290 | 500 | -505 |
| Other Operating Activity | 7,478 | -1,543 | -6,039 | -12,066 | 5,511 |
| Operating Cash Flow | $-10,417 | $-5,059 | $-22,575 | $-15,257 | $-11,322 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -122 | -100 | -493 | -473 | -359 |
| Net Acquisitions | N/A | N/A | 1,002 | 1,002 | N/A |
| Investing Cash Flow | $-122 | $-100 | $509 | $529 | $-359 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -4,920 | -3,614 | -3,590 |
| Common Stock Issued | N/A | N/A | 40,185 | N/A | N/A |
| Dividend Paid | N/A | N/A | -470 | -157 | -109 |
| Other Financing Activity | 4 | 0 | 7,818 | 7,818 | 7,139 |
| Financing Cash Flow | $4 | $N/A | $42,613 | $4,047 | $3,440 |
| Exchange Rate Effect | -1 | -1 | N/A | N/A | N/A |
| Beginning Cash Position | 31,346 | 31,346 | 10,799 | 10,799 | 10,799 |
| End Cash Position | 20,810 | 26,186 | 31,346 | 118 | 2,558 |
| Net Cash Flow | $-10,536 | $-5,160 | $20,547 | $-10,681 | $-8,241 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,417 | -5,059 | -22,575 | -15,257 | -11,322 |
| Capital Expenditure | -122 | -100 | -493 | -473 | -359 |
| Free Cash Flow | -10,539 | -5,159 | -23,068 | -15,730 | -11,681 |